Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Cefepime Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 197Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2ACS DOBFAR

    02 2ASTRAL

    03 2B BRAUN

    04 2BAXTER HLTHCARE

    05 3CHARTWELL RX

    06 2HIKMA

    07 8HOSPIRA INC

    08 3QILU ANTIBIOTICS

    09 2SAGENT PHARMS INC

    10 1SAMSON MEDCL

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    B BRAUN

    U.S.A
    Cancer Research
    Not Confirmed
    arrow

    B BRAUN

    U.S.A
    arrow
    Cancer Research
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    CEFEPIME HYDROCHLORIDE

    Brand Name : CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER

    Dosage Form : INJECTABLE;INJECTION

    Dosage Strength : EQ 1GM BASE/VIAL

    Approval Date : 2010-05-06

    Application Number : 50821

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    B BRAUN

    U.S.A
    Cancer Research
    Not Confirmed
    arrow

    B BRAUN

    U.S.A
    arrow
    Cancer Research
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    CEFEPIME HYDROCHLORIDE

    Brand Name : CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER

    Dosage Form : INJECTABLE;INJECTION

    Dosage Strength : EQ 2GM BASE/VIAL

    Approval Date : 2010-05-06

    Application Number : 50821

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    BAXTER HLTHCARE

    U.S.A
    Cancer Research
    Not Confirmed
    arrow

    BAXTER HLTHCARE

    U.S.A
    arrow
    Cancer Research
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    CEFEPIME HYDROCHLORIDE

    Brand Name : CEFEPIME IN PLASTIC CONTAINER

    Dosage Form : INJECTABLE;INJECTION

    Dosage Strength : EQ 1GM BASE/50ML (EQ 20MG BASE/ML)

    Approval Date : 2008-08-05

    Application Number : 50817

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    BAXTER HLTHCARE

    U.S.A
    Cancer Research
    Not Confirmed
    arrow

    BAXTER HLTHCARE

    U.S.A
    arrow
    Cancer Research
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    CEFEPIME HYDROCHLORIDE

    Brand Name : CEFEPIME IN PLASTIC CONTAINER

    Dosage Form : INJECTABLE;INJECTION

    Dosage Strength : EQ 2GM BASE/100ML (EQ 20MG BASE/ML)

    Approval Date : 2008-08-05

    Application Number : 50817

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    HOSPIRA INC

    U.S.A
    Cancer Research
    Not Confirmed
    arrow

    HOSPIRA INC

    U.S.A
    arrow
    Cancer Research
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    CEFEPIME HYDROCHLORIDE

    Brand Name : MAXIPIME

    Dosage Form : INJECTABLE;INJECTION

    Dosage Strength : EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Approval Date : 1996-01-18

    Application Number : 50679

    RX/OTC/DISCN : DISCN

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    HOSPIRA INC

    U.S.A
    Cancer Research
    Not Confirmed
    arrow

    HOSPIRA INC

    U.S.A
    arrow
    Cancer Research
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    CEFEPIME HYDROCHLORIDE

    Brand Name : MAXIPIME

    Dosage Form : INJECTABLE;INJECTION

    Dosage Strength : EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Approval Date : 1996-01-18

    Application Number : 50679

    RX/OTC/DISCN : DISCN

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    HOSPIRA INC

    U.S.A
    Cancer Research
    Not Confirmed
    arrow

    HOSPIRA INC

    U.S.A
    arrow
    Cancer Research
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    CEFEPIME HYDROCHLORIDE

    Brand Name : MAXIPIME

    Dosage Form : INJECTABLE;INJECTION

    Dosage Strength : EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Approval Date : 1996-01-18

    Application Number : 50679

    RX/OTC/DISCN : DISCN

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    HOSPIRA INC

    U.S.A
    Cancer Research
    Not Confirmed
    arrow

    HOSPIRA INC

    U.S.A
    arrow
    Cancer Research
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code :

    CEFEPIME HYDROCHLORIDE

    Brand Name : CEFEPIME HYDROCHLORIDE

    Dosage Form : INJECTABLE;INJECTION

    Dosage Strength : EQ 500MG BASE/VIAL

    Approval Date : 2007-06-18

    Application Number : 65369

    RX/OTC/DISCN : DISCN

    RLD : No

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    HOSPIRA INC

    U.S.A
    Cancer Research
    Not Confirmed
    arrow

    HOSPIRA INC

    U.S.A
    arrow
    Cancer Research
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code :

    CEFEPIME HYDROCHLORIDE

    Brand Name : CEFEPIME HYDROCHLORIDE

    Dosage Form : INJECTABLE;INJECTION

    Dosage Strength : EQ 1GM BASE/VIAL

    Approval Date : 2007-06-18

    Application Number : 65369

    RX/OTC/DISCN : DISCN

    RLD : No

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    HOSPIRA INC

    U.S.A
    Cancer Research
    Not Confirmed
    arrow

    HOSPIRA INC

    U.S.A
    arrow
    Cancer Research
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code :

    CEFEPIME HYDROCHLORIDE

    Brand Name : CEFEPIME HYDROCHLORIDE

    Dosage Form : INJECTABLE;INJECTION

    Dosage Strength : EQ 2GM BASE/VIAL

    Approval Date : 2007-06-18

    Application Number : 65369

    RX/OTC/DISCN : DISCN

    RLD : No

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF